front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 | |
Search for most updated materials ↑
By contrast,
in Greece (where immunisation for rubella started around 1975) vaccination coverage
remained low for a long time. It remained consistently below 50% for about 15 years
(until 1990). The slide shows the results of several studies on vaccination coverage identified in a
systematic review (at the time there was no national system to monitor vaccination
coverage). This low coverage was the result of
inconsistent immunisation policies. Around
1975, the rubella and the MMR (measles-mumps-rubella) vaccines became commercially
available in Greece. Vaccination with MMR at the age of 1-2 years started in the private
sector only, without any officially stated policy. It was only in 1989 that vaccination
with MMR in the second year of life was included in the National Immunisation Programme
and the vaccine became available in the public sector as well. Moreover, no policy to vaccinate susceptible women of childbearing age was implemented.
|